Calcium-sensing by parathyroid glands in secondary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2765-2772

  Goodman, William G ^a,d   Veldhuis, Johannes D ^b   Belin, Thomas R ^a   Van Herle, Andre J ^a   Juppner, Harald ^c   Salusky, Isidro B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; CALCIUM BALANCE; CALCIUM CELL LEVEL; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; HYPERCALCIURIA; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PRIORITY JOURNAL; UREMIA;

ADOLESCENT; ADULT; AGED; CALCIUM; CHILD; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM, SECONDARY; KINETICS; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROIDECTOMY; UREMIA;

EID: 0031727116     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2765     Document Type: Article

References (38)

1. Auwerx J, Demedts M, Bouillon R. 1984 Altered parathyroid set point to calcium in familial hypocalciuric hypercalcaemia. Acta Endocrinol (Copenh). 106:215-218.
2. Khosla S, Ebelling PR, Firek AF, Burritt MM, Kao PC, Heath HH. 3rd. 1993 Calcium infusion suggests a "set point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab. 76:715-720.
3. Heath H. 3rd 1994 Familial benign hypercalcemia - from clinical description to molecular genetics. West J Med. 160:554-561.
4. Pollak MR, Chou YH, Marx SJ, et al. 1994 Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest. 93:1108-1112.
5. Brown EM, Gardner DG, Brennan MF, et al. 1979 Calcium-regulated parathyroid hormone release in primary hyperparathyroidism: studies in vitro with dispersed parathyroid cells. Am J Med. 66:923-931.
6. Brown EM, Wilson RE, Thatcher JG, Marynick SP. 1981 Abnormal calcium-regulated PTH release in normal parathyroid tissue from patients with adenoma. Am J Med. 71:565-570.
7. Brown EM. 1983 Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab. 56:572-581.
8. Gardin JP, Patron P, Fouqueray B, Prigent A, Paillard M. 1988 Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies. Miner Electrolyte Metab. 14:221-228.
9. Goodman WG, Salusky IB. 1996 Parathyroid gland function and the set point for PTH release: understanding the available data. Nephrol Dial Transplant. 11:16-18.
10. Felsenfeld AJ, Llach F. 1993 Parathyroid gland function in chronic renal failure. Kidney Int. 43:771-789.
11. Rodriguez M, Felsenfeld AJ. 1996 The set point of calcium: another view. Nephrol Dial Transplant. 11:1722-1725.
12. Felsenfeld AJ, Rodriguez M, Dunlay R, Llach F. 1991 A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy. Nephrol Dial Transplant. 6:244-251.
13. Ramirez JA, Goodman WG, Gombein J, et al. 1993 Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. J Clin Endocrinol Metab. 76:1489-1494.
14. Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F. 1989 Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int. 36:1093-1098.
15. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E. 1989 Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest. 83:1349-1355.
16. Malberti F, Surian M, Cosci P. 1993 Improvement of secondary hyperparathyroidism and reduction of the set-point of calcium after intravenous calcitriol. Kidney Int. 41:5125-5130.
17. Goodman WG, Belin T, Gales B, Jüppner H, Segre GV, Salusky IB. 1995 Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism. Kidney Int. 48:1553-1558.
18. Goodman WG, Belin TR, Salusky IB. 1996 In vivo assessments of calcium-regulated parathyroid hormone release in secondary hyperparathyroidism. Kidney Int. 50:1834-1844.
19. Salusky IB, Coburn JW, Brill J, et al. 1988 Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int. 33:975-982.
20. Conlin PR, Fajtova VT, Mortensen RM, Leboff MS, Brown EM. 1989 Hysteresis in the relationship between serum ionized calcium and intact parathyroid hormone during recovery from induced hyper- and hypocalcemia in normal humans. J Clin Endocrinol Metab. 69:593-599.
21. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. 1987 Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 33:1364-1367.
22. Reinhardt TA, Horst RL, Orf JW, Hollis BW. 1984 A microassay for 1,25 dihydroxyvitamin D not requiring high performance liquid chromatography. J Clin Endocrinol Metab. 58:91-98.
23. Dixon WJ, Massey FJ. 1983 Introduction to statistical analysis. New York; McGraw Hill Book Co. pp 189-222.
24. Straume M, Veldhuis JD, Johnson ML. 1994 Model-independent quantification of measurement error: empirical estimation of discrete variance function profiles based on standard curves. Methods Enzymol. 240:121-150.
25. Stark DD, Gooding GA, Moss AA, Clark OH, Ovenfors CO. 1983 Parathyroid imaging: comparison of high-resolution CT and high-resolution sonography. Am J Roentgenol. 141:633-638.
26. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest. 92:1436-1443.
27. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drücke TB. 1995 Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest. 95:2047-2053.
28. Messa P, Vallone C, Mioni G, Geatti O, Turrin D, Passoni N, Cruciatti A. 1994 Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients. Kidney Int. 46:1713-1720.
29. Indridason OS, Heath H, III, Khosla S, Yohay DA, Quarles LD. 1996 Nonsuppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Kidney Int. 50:1663-1671.
30. Brown EM, Wilson RE, Eastmen RC, Pallotta J, Marynick S. 1982 Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab. 54:172-179.
31. 3. Arch Intern Med 143:1205-1211.
32. Wallfelt C, Gylfe E, Larsson R, Ljunghall S, Rastad J, Akerstrom G. 1988 Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism. J Endocrinol. 116:457-464.
33. Wallfelt C, Larsson R, Gylfe E, Ljunghall S, Rastad J, Akerstrom G. 1988 Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism - implications for parathyroid gland autotranplantation. World J Surg. 12:431-436.
34. Rudberg C, Akerstrom G, Ljunghall S, et al. 1982 Regulation of parathyroid hormone release in primary and secondary hyperparathyroidism -studies in vivo and in vitro. Acta Endocrinol (Copenh). 101:408-413.
35. +2-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab. 81:1598-1606.
36. D'Amour P, Rousseau L, Rocheleau B, Pomier-Layrargues G, Huet PM. 1996 Influence of Ca2+ concentration on the clearance and circulating levels of intact and carboxy-terminal iPTH in pentobarbital-anesthetized dogs. J Bone Miner Res. 11:1075-1085.
37. Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barre M, D'Amour P. 1996 Accumulation of a non-(1-48) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab. 81:3923-3929.
38. Freitag J, Martin KJ, Hruska KA, et al. 1978 Impaired parathyroid hormone metabolism in patients with chronic renal failure. N Engl J Med. 298:29-32.